BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31640763)

  • 21. Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension.
    Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
    Oral Oncol; 2018 Nov; 86():188-194. PubMed ID: 30409299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment for T1-2 oral squamous cell carcinoma with or without perineural invasion: neck dissection and postoperative adjuvant therapy.
    Tai SK; Li WY; Yang MH; Chang SY; Chu PY; Tsai TL; Wang YF; Chang PM
    Ann Surg Oncol; 2012 Jun; 19(6):1995-2002. PubMed ID: 22203180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes for patients with second primary malignancy after primary surgical treatment for early-stage squamous cell carcinoma of the oral cavity.
    Suton P; Prpic M; Tarle M; Mamic M; Nikles I; Luksic I
    Head Neck; 2018 Nov; 40(11):2347-2352. PubMed ID: 30302872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neck management of pathological N1 oral squamous cell carcinoma: a retrospective study.
    Chen Z; Zhang WB; Wang Y; Mao C; Guo CB; Peng X
    Int J Oral Maxillofac Surg; 2023 Jul; 52(7):735-743. PubMed ID: 36376175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer.
    D'Cruz AK; Vaish R; Kapre N; Dandekar M; Gupta S; Hawaldar R; Agarwal JP; Pantvaidya G; Chaukar D; Deshmukh A; Kane S; Arya S; Ghosh-Laskar S; Chaturvedi P; Pai P; Nair S; Nair D; Badwe R;
    N Engl J Med; 2015 Aug; 373(6):521-9. PubMed ID: 26027881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.
    O'Brien CJ; Traynor SJ; McNeil E; McMahon JD; Chaplin JM
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):360-5. PubMed ID: 10722009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer.
    Schilling C; Stoeckli SJ; Haerle SK; Broglie MA; Huber GF; Sorensen JA; Bakholdt V; Krogdahl A; von Buchwald C; Bilde A; Sebbesen LR; Odell E; Gurney B; O'Doherty M; de Bree R; Bloemena E; Flach GB; Villarreal PM; Fresno Forcelledo MF; Junquera Gutiérrez LM; Amézaga JA; Barbier L; Santamaría-Zuazua J; Moreira A; Jacome M; Vigili MG; Rahimi S; Tartaglione G; Lawson G; Nollevaux MC; Grandi C; Donner D; Bragantini E; Dequanter D; Lothaire P; Poli T; Silini EM; Sesenna E; Dolivet G; Mastronicola R; Leroux A; Sassoon I; Sloan P; McGurk M
    Eur J Cancer; 2015 Dec; 51(18):2777-84. PubMed ID: 26597442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morbidity of neck dissection submuscular recess (sublevel IIb) in head and neck cancer].
    Roger V; Hitier M; Robard L; Babin E
    Rev Laryngol Otol Rhinol (Bord); 2014; 135(3):135-40. PubMed ID: 26521356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial.
    Lang P; Contreras J; Kalman N; Paterson C; Bahig H; Billfalk-Kelly A; Brennan S; Rock K; Read N; Venkatesan V; Sathya J; Mendez LC; MacNeil SD; Nichols AC; Fung K; Mendez A; Winquist E; Kuruvilla S; Stewart P; Warner A; Mitchell S; Theurer JA; Palma DA
    Radiat Oncol; 2020 Aug; 15(1):196. PubMed ID: 32795322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients.
    El-Naaj IA; Leiser Y; Shveis M; Sabo E; Peled M
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2674-9. PubMed ID: 21571415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Kif5b protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma.
    Luan YJ; Xu Y; Cai J; Dou Y; Yu WJ; Wang KT; Liu SH; Yang PS; Qu X; Wei FC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4542-4550. PubMed ID: 30058692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trial.
    Miura K; Hirakawa H; Uemura H; Yoshimoto S; Shiotani A; Sugasawa M; Homma A; Yokoyama J; Tsukahara K; Yoshizaki T; Yatabe Y; Matsuo K; Ohkura Y; Kosuda S; Hasegawa Y
    Auris Nasus Larynx; 2017 Jun; 44(3):319-326. PubMed ID: 27496008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of factors associated with the risk stratification of survivorship for stage IV squamous cell carcinoma of the oral cavity: A 10-year retrospective study.
    Cheng HC; Yang CC; Kao SY; Wu TY; Wu CH
    J Chin Med Assoc; 2020 May; 83(5):491-499. PubMed ID: 32132387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.
    Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supraomohyoid neck dissection and modified radical neck dissection for clinically node-negative oral squamous cell carcinoma: a prospective study of prognosis, complications and quality of life.
    Guo CB; Feng Z; Zhang JG; Peng X; Cai ZG; Mao C; Zhang Y; Yu GY; Li JN; Niu LX
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1885-90. PubMed ID: 25175079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer.
    Iype EM; Sebastian P; Mathew A; Balagopal PG; Varghese BT; Thomas S
    Oral Oncol; 2008 Dec; 44(12):1134-8. PubMed ID: 18486527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2b or not 2b? Shoulder function after level 2b neck dissection: A double-blind randomized controlled clinical trial.
    Dziegielewski PT; McNeely ML; Ashworth N; O'Connell DA; Barber B; Courneya KS; Debenham BJ; Seikaly H
    Cancer; 2020 Apr; 126(7):1492-1501. PubMed ID: 31873950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of sentinel lymph node scintigraphy and intraoperative gamma probing with gold standard elective neck dissection in patients with N0 oral squamous cell cancers.
    Sundaram PS; Subramanyam P
    Nucl Med Commun; 2019 Nov; 40(11):1138-1147. PubMed ID: 31568193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preserving level IIb lymph nodes in elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma.
    Lim YC; Song MH; Kim SC; Kim KM; Choi EC
    Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1088-91. PubMed ID: 15381596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel node biopsy in lieu of neck dissection for staging oral cancer.
    Rigual N; Loree T; Frustino J; Jayaprakash V; Cohan D; Sullivan M; Kuriakose MA
    JAMA Otolaryngol Head Neck Surg; 2013 Aug; 139(8):779-82. PubMed ID: 23868306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.